Mark Brandt

Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

Deborah A. Thomas, Stefan Faderl, Susan O’Brien et al. · Cancer · 2006 · 564 citations

Medicine, Immunology, Oncology +14

Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia

Farhad Ravandi, Jörge E. Cortes, Daniel M. Jones et al. · Journal of Clinical Oncology · 2010 · 356 citations · Full text

Medicine, Oncology, Pharmacology +16

Characteristics, clinical outcome, and prognostic significance of <scp>IDH</scp> mutations in <scp>AML</scp>

Courtney D. DiNardo, Farhad Ravandi, Sam Agresta et al. · American Journal of Hematology · 2015 · 315 citations · Full text

Medicine, Oncology, Cancer Genetics +15

Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab

Yasmin Abaza, Hagop M. Kantarjian, Guillermo Garcia‐Manero et al. · Blood · 2016 · 297 citations · Full text

Medicine, Hematology, Oncology +17

Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia

Sima Jeha, Varsha Gandhi, Ka Wah Chan et al. · Blood · 2003 · 258 citations · Full text

Medicine, Oncology, Pharmacology +12